1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow FGFR2 Gene Translocation: new trials by email Literature Review of FGFR2 Gene Translocation trials Research Report on FGFR2 Gene Translocation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements Pemigatinib - Intrahepatic Cholangiocarcinoma, FGFR2 Gene Mutation | Phase 2 | Terminated | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2 | 2022-11-11 | 2025-04-13 |
Adenocarcinoma (1) · Carcinoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
pemigatinib (1)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1)
Germany (1)
Salah-Eddin Al-Batran, Prof. Dr. (1) · Thorsten Goetze, Prof. Dr. (1)